Sort
82,697 grants matching “vaccine development”
Enveloped Virus Glycoprotein/receptor Interactions
$947,359Edward Berger · Niaid Extramural Activities · Z01 · FY2007 · AI
Cellular and Developmental Biology of Coxiella burnetii
$947,280Robert A Heinzen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
rVSV Vectored Vaccine to Protect Against Ebola and Marburg Viruses
$947,203John H Eldridge · Profectus Biosciences, Inc. · R01 · FY2015 · AI
iCAN-PREVENT: MD Anderson International Cancer Prevention Clinical Trial Consortium
$947,195Powel H Brown · University Of Tx Md Anderson Can Ctr · UG1 · FY2019 · CA
Clinical Trials of Haploidentical Hematopoietic Stem Cell Transplantation and Vac
$947,110Nelson J. Chao · Duke University · P01 · FY2012 · CA
In-Vitro Culture of Plasmodium falciparum Sporozoites for Malaria Vaccine
$947,054Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2022 · AI
Quintiles Clinical Trial Unit for HIV/AIDS Clinical Trials Networks
$946,844Kathleen E. Squires · Quintiles Federated Services, Inc. · U01 · FY2008 · AI
Immunopathogenesis of Fungal Infections
$946,840Michail Lionakis · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Boosting efficacy of oral vaccine candidates by enabling spore display of nitrated antigens
$946,800Aditya Mohan Kunjapur · University Of Delaware · DP2 · FY2025 · AI
Psoralen-Killed, Metabolically-Active Anthrax Vaccine
$946,796Thomas W. Dubensky · Cerus Corporation · U01 · FY2006 · AI
Specific Pathogen Free Baboon Research Resource (SPFBRR)
$946,402Christian R Abee · University Of Tx Md Anderson Can Ctr · P40 · FY2017 · OD
Inducing HIV-1 NAb Breadth by Native Trimer Prime-Boost Vaccination
$946,370James M Binley · San Diego Biomedical Research Institute · R01 · FY2023 · AI
A Phase I Open Label, Dose Escalation Clinical Trial assessing the Safety, Tolerability, and Feasibility of pNGLV4aCRTE6E7L2 HPV DNA vaccine administration via Intramuscular TriGridTM Ele
$946,290Howard Bailey · University Of Wisconsin-Madison · N01 · FY2018 · CA
Multivalent Vaccine for Viral Hemorrhagic Fever
$946,260Thomas William Geisbert · Boston University Medical Campus · U01 · FY2009 · AI
Host Immune Responses to Antigens of Malaria Parasites
$946,156Carole Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Task A11: SMALL ANIMAL MODELS FOR BIODEFENSE VIRUSES
$946,052John Morrey · Utah State University · N01 · FY2019 · AI
Influence of SIV replication on TB progression and immunity
$945,816Zandrea Ambrose · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AI
Identification of Novel Broad Spectrum Influenza Virus Inhibitors
$945,791Arnab Basu · Microbiotix, Inc · R44 · FY2014 · AI
Novel vaccine strategies to induce V2 apex-directed broad neutralizing antibodies
$945,717Laurent Karl Verkoczy · Applied Biomedical Science Institute · R01 · FY2023 · AI
A Solid-Phase, Long-Acting CCR5 Monoclonal Antibody for HIV Transmission
$945,533Jonah B. Sacha · Oregon Health & Science University · R01 · FY2022 · AI
Development of Non-Human Primate Models to Assess Immunological Mechanisms and Antigenic Targets of Protective Sporozoite (SPZ) Vaccines and Establish Superior Efficacy of Next Generation SPZ vaccines
$945,493Stephen Lev Hoffman · Sanaria, Inc. · U01 · FY2025 · AI
Active Immunization for Treating Methamphetamine Abuse
$945,482S. Michael Owens · Univ Of Arkansas For Med Scis · U01 · FY2009 · DA
Virus Clearance from the Central Nervous System
$945,437Douglas Craig Hooper · Thomas Jefferson University · R01 · FY2014 · AI
Virus Clearance from the Central Nervous System
$945,437Douglas Craig Hooper · Thomas Jefferson University · R01 · FY2012 · AI
Virus Clearance from the Central Nervous System
$945,437Douglas Craig Hooper · Thomas Jefferson University · R01 · FY2015 · AI